Abstract
This review shows how tumor antigen cross-presentation is affected by the major therapeutic modalities including chemotherapy, radiotherapy, and surgery. We argue that this process could affect the way that a tumor works as its own cellular vaccine, and that it is differentially modulated by the choice of treatment.
Original language | English |
---|---|
Pages (from-to) | 601-604 |
Journal | Cancer Research |
Volume | 66 |
Issue number | 2 |
DOIs | |
Publication status | Published - 2006 |